Emerging Growth Research Reiterates Buy-Emerging Rating and $9.00 Price Target on Virtuix Following Strong Fiscal Q1 2027 Results

Emerging Growth Research reiterated a Buy rating and $9 price target on Virtuix, noting that fiscal Q1 revenue of $0.8 million beat its $0.5 million estimate despite a year-over-year decline. The report highlighted accelerating new orders, which grew 72% year-over-year and 150% since the June 2026 Meta partnership launched, alongside improved gross margins of 30%. The firm projects a potential revenue inflection point in 2028, driven by the new Meta distribution channel and expanding defense applications with the U.S.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.